Penicillin G potassium: Difference between revisions
No edit summary |
|||
Line 24: | Line 24: | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
Penicillin G is bactericidal against penicillin-susceptible microorganisms during the stage of active multiplication. It acts by inhibiting biosynthesis of cell-wall mucopeptide. It is not active against the penicillinase-producing bacteria, which include many strains of staphylococci. Penicillin G is highly active in vitro against staphylococci (except penicillinase-producing strains), streptococci (groups A, B, C, G, H, L and M), pneumococci and Nelsseriameningitidis. Other organisms susceptible in vitro to penicillin G are Nelsseriagonorrhoeae, Corynebacteriumdiphtheriae, Bacillus anthracis, clostridia, Actinomycesspecies, Spirillum minus, Streptobacillusmonillformis, Listeria monocytogenes, and leptospira; Treponemapallidumis extremely susceptible.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PENICILLIN G POTASSIUM INJECTION, POWDER, FOR SOLUTION [SANDOZ INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=91950983-4884-40d1-abd8-bcc953d61b7f | publisher = | date = | accessdate}}</ref> | |||
==References== | ==References== |
Revision as of 03:10, 3 January 2014
Penicillin G potassium |
---|
PENICILLIN G POTASSIUM® FDA Package Insert |
Description |
Clinical Pharmacology |
Microbiology |
Indications and Usage |
Contraindications |
Warnings and Precautions |
Adverse Reactions |
Overdosage |
Dosage and Administration |
How Supplied |
Labels and Packages |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Category
US Brand Names
PENICILLIN G POTASSIUM®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Dosage and Administration | How Supplied | Labels and Packages
Mechanism of Action
Penicillin G is bactericidal against penicillin-susceptible microorganisms during the stage of active multiplication. It acts by inhibiting biosynthesis of cell-wall mucopeptide. It is not active against the penicillinase-producing bacteria, which include many strains of staphylococci. Penicillin G is highly active in vitro against staphylococci (except penicillinase-producing strains), streptococci (groups A, B, C, G, H, L and M), pneumococci and Nelsseriameningitidis. Other organisms susceptible in vitro to penicillin G are Nelsseriagonorrhoeae, Corynebacteriumdiphtheriae, Bacillus anthracis, clostridia, Actinomycesspecies, Spirillum minus, Streptobacillusmonillformis, Listeria monocytogenes, and leptospira; Treponemapallidumis extremely susceptible.[1]
References
- ↑ "PENICILLIN G POTASSIUM INJECTION, POWDER, FOR SOLUTION [SANDOZ INC]". Text " accessdate" ignored (help)
Adapted from the FDA Package Insert.